Blog

Top Posts

Meet our Executive Vice President for the Americas, LaQuinta Jernigan

Posted

Passionate about putting the patient at the heart of everything we do, LaQuinta shares what she has learnt through the challenges of the pandemic, what she thinks sets us apart from our competitors, and what exciting developments we can expect to see for the company in 2021.

Meet our Chief Executive Officer, Tarquin Scadding-Hunt

Posted

Our CEO Tarquin Scadding-Hunt has more than 20 years’ experience in the pharma industry and has overseen many exciting developments in the business.

Passionate about making sure we do everything with compassion and kindness – inside and outside the business – Tarquin shares with us his vision for the company, what makes us different, and how he’s supporting us to create remarkable patient experiences.

The Importance of the Patient Voice to the 21st Century Cures Act

Posted

The 21st Century Cures Act was nothing short of revolutionary. Signed into U.S. law on December 13th 2016, it is designed to support the acceleration of medical product development and bring new innovations and advances to patients who need them (FDA.com).

Meet our Chief Operating Officer, Christopher Kennedy

Posted

Christopher Kennedy has recently joined the mdgroup team as Chief Operating Officer, based out of our North Carolina office. Christopher has been working in the Healthcare Provider, Pharmaceutical, Biotechnology, and Medical Device sectors for the last 20 years, and is a champion for improving the patient experience in all facets of care.

Patient Engagement

How Can We Increase Public Awareness of Clinical Trials?

Posted

Here, we outline the biggest barriers to awareness of clinical research, the roles healthcare practitioners and clinical trial advocates can play in the education of prospective patients, and the most effective ways of improving clinical trial awareness amongst the general public.

Decentralised Trials

How to Involve Patients in the Design of Decentralised Clinical Trials

Posted

There’s no doubt of the seismic impact COVID-19 has had on clinical trials. As a result of safety measures, the industry has had no choice but to start moving towards an approach which minimises or eliminates the need for travel and contact. As a result, more and more trials are being held virtually, and completely decentralised trials are increasingly more common.